BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04634877-completion@plaintrial.com
DTSTAMP:20261027T202131Z
DTSTART;VALUE=DATE:20260915
SUMMARY:Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemo
 therapy With or Without Radiotherapy in Participants With Newly Diagnosed 
 Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNO
 TE-B21 / ENGOT-en11 / GOG-3053) — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT04634877
URL:https://plaintrial.com/trial/NCT04634877
END:VEVENT
END:VCALENDAR